Skip to main content
OpenTrials
Completed

NCT Number: NCT03498703

Azathioprine in Recurrent Implantation Failure

Azathioprine increase pregnancy rate in patients with recurrent implantation failure

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Recurrent Implantation Failure In Vitro Fertilization Intracytoplsmic Sperm Injection

Age range

20 year–39 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 2

Primary location

Ain Shams University, Maternity Hospital, Cairo, Egypt

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age: 20-39
  • previous 3 or more failed ivf

Exclusion criteria

  • intrauterine anomalies
  • chronic systemic illness
  • chronic pelvic conditions
  • sensitivety to azathioprine

Treatment and study plan

Azathioprine Pill

Drug

Azathioprine increase pregnancy rate in cases with recurrent implantaion failure

Placebo oral tablet

Drug

Placebo tablets

Primary outcomes

  1. Clinical pregnancy rate

    Time frame: 2 weeks

Secondary outcomes

  1. Side effects

    Time frame: 2 weeks

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Collaborators

  • Capital Birth Center

Registry information

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Apr 17, 2018
Registry last updated
Jul 24, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.